Telomir Pharmaceuticals (TELO) EBITDA

Annual EBITDA

-$12.19 M
-$765.40 K-6.70%

December 31, 2024


Summary


Performance

TELO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTELOprofitabilitymetrics:

Quarterly EBITDA

-$2.90 M
+$3.09 M+51.62%

December 31, 2024


Summary


Performance

TELO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTELOprofitabilitymetrics:

TTM EBITDA

-$12.25 M
+$5.67 M+31.62%

December 31, 2024


Summary


Performance

TELO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTELOprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TELO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.7%0.0%0.0%
3 y3 years-8730.0%0.0%0.0%
5 y5 years-8730.0%0.0%0.0%

TELO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8730.0%at low-4034.7%+66.2%<-9999.0%+31.6%
5 y5-year-8730.0%at low-4034.7%+66.2%<-9999.0%+31.6%
alltimeall time-8730.0%at low-4034.7%+66.2%<-9999.0%+31.6%

Telomir Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$12.19 M(+6.7%)
-$2.90 M(-51.6%)
-$12.25 M(-31.6%)
Sep 2024
-
-$5.99 M(+313.4%)
-$17.92 M(+39.1%)
Jun 2024
-
-$1.45 M(-24.4%)
-$12.88 M(+0.2%)
Mar 2024
-
-$1.92 M(-77.6%)
-$12.86 M(+12.5%)
Dec 2023
-$11.43 M
-$8.57 M(+797.7%)
-$11.43 M(+241.1%)
Sep 2023
-
-$954.20 K(-33.1%)
-$3.35 M(+27.4%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$1.43 M(+195.4%)
-$2.63 M(+106.5%)
Mar 2023
-
-$482.90 K(-0.9%)
-$1.27 M(+61.1%)
Dec 2022
-$854.10 K(+518.5%)
-
-
Dec 2022
-
-$487.10 K(+108.6%)
-$790.70 K(+160.4%)
Sep 2022
-
-$233.50 K(+233.1%)
-$303.60 K(+333.1%)
Jun 2022
-
-$70.10 K
-$70.10 K
Dec 2021
-$138.10 K
-
-

FAQ

  • What is Telomir Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Telomir Pharmaceuticals?
  • What is Telomir Pharmaceuticals annual EBITDA year-on-year change?
  • What is Telomir Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Telomir Pharmaceuticals?
  • What is Telomir Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Telomir Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Telomir Pharmaceuticals?
  • What is Telomir Pharmaceuticals TTM EBITDA year-on-year change?

What is Telomir Pharmaceuticals annual EBITDA?

The current annual EBITDA of TELO is -$12.19 M

What is the all time high annual EBITDA for Telomir Pharmaceuticals?

Telomir Pharmaceuticals all-time high annual EBITDA is -$138.10 K

What is Telomir Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, TELO annual EBITDA has changed by -$765.40 K (-6.70%)

What is Telomir Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of TELO is -$2.90 M

What is the all time high quarterly EBITDA for Telomir Pharmaceuticals?

Telomir Pharmaceuticals all-time high quarterly EBITDA is -$70.10 K

What is Telomir Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, TELO quarterly EBITDA has changed by $0.00 (0.00%)

What is Telomir Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of TELO is -$12.25 M

What is the all time high TTM EBITDA for Telomir Pharmaceuticals?

Telomir Pharmaceuticals all-time high TTM EBITDA is -$70.10 K

What is Telomir Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, TELO TTM EBITDA has changed by $0.00 (0.00%)